SUMF1 Antibodies

Santa Cruz Biotechnology delivers a wide array of SUMF1 monoclonal antibodies for investigating SUMF1's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUMF1, or sulfatase-modifying factor 1, plays a vital role in the post-translational modification of sulfatases, which are enzymes involved in the degradation of sulfated glycosaminoglycans. The proper functioning of SUMF1 is essential for maintaining cellular homeostasis and regulating various biological pathways, including those related to development and disease. Dysregulation of SUMF1 has been linked to several pathological conditions, making it an important focus of scientific investigation. Research has shown that SUMF1 activity influences multiple cellular pathways and metabolic processes. Understanding SUMF1's molecular mechanisms can provide valuable insights into disease progression and potential therapeutic approaches. Current studies continue to uncover new aspects of SUMF1's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SUMF1's impact on human health and disease.